We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$492B
AUM Growth
+$21.5B
Cap. Flow
-$23.6B
Cap. Flow %
-4.79%
Top 10 Hldgs %
30.05%
Holding
13,811
New
1,370
Increased
4,863
Reduced
5,559
Closed
1,867

Sector Composition

Rank Sector Weight
1 Technology 2.7%
2 Consumer Discretionary 1.66%
3 Financials 1.18%
4 Communication Services 1.07%
5 Healthcare 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPS
13301
PUT
DELISTED
Altus Power
AMPS
-15,700
Closed -$86K
PYCR
13302
CALL
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
-30,800
Closed -$817K
SKGRW
13303
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
-12,827
Closed -$2.06K
HCVIU
13304
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
-10,815
Closed -$110K
TBNK
13305
CALL
DELISTED
Territorial Bancorp Inc.
TBNK
-10,700
Closed -$207K
TBNK
13306
DELISTED
Territorial Bancorp Inc.
TBNK
-43,237
Closed -$835K
XDAP
13307
DELISTED
Innovator U.S. Equity Accelerated ETF - April
XDAP
-11,269
Closed -$298K
BACK
13308
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
-4,683
Closed -$20.1K
TCBPW
13309
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
-14,174
Closed -$1.41K
ACHL
13310
DELISTED
Achilles Therapeutics
ACHL
-13,900
Closed -$13.3K
SYRS
13311
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-19,633
Closed -$63.1K
CUTR
13312
CALL
DELISTED
Cutera, Inc.
CUTR
-67,900
Closed -$1.6M
BEST
13313
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
-6,404
Closed -$20.2K
PWUPU
13314
DELISTED
PowerUp Acquisition Corp. Unit
PWUPU
-11,134
Closed -$117K
RFACR
13315
DELISTED
RF Acquisition Corp. Rights
RFACR
-11,820
Closed -$1.77K
CTV
13316
DELISTED
Innovid Corp.
CTV
-32,464
Closed -$45.8K
SNAX
13317
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
-1,137
Closed -$8.27K
CDMO
13318
PUT
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-29,100
Closed -$546K
BCOV
13319
CALL
DELISTED
Brightcove, Inc.
BCOV
-12,800
Closed -$57K
BMTX
13320
CALL
DELISTED
BM Technologies, Inc.
BMTX
-169,100
Closed -$595K
CRKN
13321
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
-$3.55K
VINC
13322
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
-1,356
Closed -$28.2K
GATO
13323
DELISTED
Gatos Silver, Inc.
GATO
-38,146
Closed -$206K
LATGU
13324
DELISTED
Chenghe Acquisition I Co. Unit
LATGU
-22,220
Closed -$233K
RGF
13325
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
-1,284
Closed -$65K

Similar funds

Jeff Yass's Q2 2023 Portfolio in Review

As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass withdrew a net $23.6B in Q2 2023, closing 1,867 positions and reducing 5,559 holdings. Its most notable exit was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $45.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, up from 2.3% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in State Street SPDR Portfolio Aggregate Bond ETF worth $32.9M.

  • Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
  • Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
  • Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
  • Jeff Yass opened 1,370 new positions and closed 1,867 in Q2 2023.
  • Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.